No one is prepared to hear that they have an incurable type of cancer. And their doctors don't want to try a new treatment that hasn't already been tried on hundreds of patients.
But if we look at the cancer's DNA, we can find similar cancers, and how they responded to various drugs. We call this Precision Medicine, and our experts work with your doctor to choose the best DNA test that shortlist treatments personalized to your clinical history.
With a team of specialty oncologists, molecular biologists, computer scientists, and reimbursement experts, we assist in the following areas:
Selin Kurnaz CEO of MassiveBio, Inc. was Interviewed on BizTalkRadio’s “The Big Biz Show”. Watch now
NEW YORK (GenomeWeb) – New York-based healthcare informatics startup Massive Bio is seeking early-access customers willing to participate in two pilot projects to test an onsite version of its oncology clinical decision support system (CDSS), scheduled for launch this summer, as well as an on-demand service option of the same platform. Read more
We often hear that every patient’s cancer is unique. This may refer to the different ways tumors start and spread, how they can react differently to the same treatment, or how each patient may have different symptoms. Read more